High prevalence of unmet healthcare need among people who use illicit drugs in a Canadian setting with publicly-funded interdisciplinary primary care clinics
Restricted accessResearch articleFirst published online October, 2021
High prevalence of unmet healthcare need among people who use illicit drugs in a Canadian setting with publicly-funded interdisciplinary primary care clinics
People who use illicit drugs (PWUD) experience significant barriers to healthcare. However, little is known about levels of attachment to primary care (defined as having a regular family doctor or clinic they feel comfortable with) and its association with unmet healthcare needs in this population. In a Canadian setting that features novel publicly-funded interdisciplinary primary care clinics, we sought to examine the prevalence and correlates (including attachment to primary care) of unmet healthcare needs among PWUD.
Methods
Data were derived from two prospective cohort studies of PWUD in Vancouver, Canada between December 2017 and November 2018. Multivariable logistic regression was used to identify factors associated with self-reported unmet healthcare needs among participants reporting any health issues.
Results
In total, 743 (83.6%) of 889 eligible participants reported attachment to primary care and 220 (24.7%) reported an unmet healthcare need. In multivariable analyses, attachment to primary care at an integrated care clinic (adjusted odds ratio [AOR] = 0.14; 95% Confidence Interval [CI]: 0.06–0.34) was negatively associated with an unmet healthcare need, while being treated poorly at a healthcare facility (AOR = 5.50; 95% CI: 3.59–8.60) and self-reported chronic pain (AOR = 2.00, 95% CI: 1.30–3.01) were positively associated with an unmet healthcare need.
Conclusion
Despite the high level of attachment to primary care, a quarter of our sample reported an unmet healthcare need. Our findings suggest that multi-level interventions are required to address the unmet need, including pain management and integrated care, to support PWUD with complex health needs.
WalkerER, PrattLA, SchoenbornCA, DrussBG.Excess mortality among people who report lifetime use of illegal drugs in the United States: a 20-year follow-up of a nationally representative survey. Drug Alcohol Depend. 2017;171:31–38.
2.
Office of the Surgeon General (US). Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. Washington, DC: Office of the Surgeon General; 2016.
3.
ChitwoodD, McBrideDC, MetschLR, ComerfordM, McCoyCB.A comparison of the need for health care and use of health care by injection-drug users, other chronic drug users, and nondrug users. Am Behav Sci. 1998;41(8):1107–1122.
4.
McCoyCB, MetschLR, ChitwoodDD, MilesC.Drug use and barriers to use of health care services. Subst Use Misuse. 2001;36(6–7):789–804.
IslamMM, ToppL, DayCA, DawsonA, ConigraveKM.The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature. Int J Drug Policy. 2012;23(2):94–102.
7.
SaitzR, DaalemanTP.Now is the time to address substance use disorders in primary care. Ann Fam Med. 2017;15(4):306–308.
8.
WeisnerC, MertensJ, ParthasarathyS, MooreC, LuY.Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001;286(14):1715–1723.
9.
KorownykC, PerryD, TonJ, . Managing opioid use disorder in primary care. Can Fam Physician. 2019;65(5):321–330.,
ParthasarathyS, MertensJ, MooreC, WeisnerC.Utilization and cost impact of integrating substance abuse treatment and primary care. Med Care. 2003;41(3):357–367.
12.
GordonAJ, DrexlerK, HawkinsEJ, . Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Subst Abus. 2020;41(3):275–282.
LindenIA, MarMY, WerkerGR, JangK, KrauszM.Research on a vulnerable neighborhood-the vancouver downtown eastside from 2001 to 2011. J Urban Health. 2013;90(3):559–573.
Al-TayyibAA, ThiedeH, BurtRD, KoesterS.Unmet health care needs and hepatitis C infection among persons who inject drugs in denver and seattle. Prev Sci. 2015;16(2):330–340.
18.
SteinMD, FriedmannP.Need for medical and psychosocial services among injection drug users: a comparative study of needle exchange and methadone maintenance. Am J Addict. 2002;11(4):262–270.
19.
McKnightC, ShumwayM, MassonCL, . Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization. J Ethn Subst Abuse. 2017;16(4):404–419.
20.
van BoekelLC, BrouwersEPM, van WeeghelJ, GarretsenHFL.Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35.
21.
AhernJ, StuberJ, GaleaS.Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 2007;88(2–3):188–196.
22.
LimS, HarrisTG, NashD, LennonMC, ThorpeLE.All-cause, drug-related, and hiv-related mortality risk by trajectories of jail incarceration and homelessness among adults in New York City. Am J Epidemiol. 2015;181(4):261–270.
23.
LambdinBH, ComfortM, KralAH, LorvickJ.Accumulation of jail incarceration and hardship, health status, and unmet health care need among women who use drugs. Womens Health Issues. 2018;28(5):470–475.
24.
MilloyMJ, KerrT, BuxtonJ, . Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215–1221.
25.
OldingM, HayashiK, PearceL, . Developing a patient-reported experience questionnaire with and for people who use drugs: a community engagement process in Vancouver's Downtown Eastside. Int J Drug Policy. 2018;59:16–23.
26.
WoodE, KerrT, MarshallBDL, . Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338(1):b1649–b1194.
27.
BroderickJE, DeWittEM, RothrockN, CranePK, ForrestCB.Advances in patient-reported outcomes: the NIH PROMIS® measures. EGEMS. 2013;1(1):1015.
28.
MerskeyH.Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Pain. 1986;3:S1–S226.
29.
HayashiK, MilloyM-J, LysyshynM, . Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: a cross-sectional urine toxicology screening study. Drug Alcohol Depend. 2018;183:1–6.
McCreaddieM, LyonsI, WattD, . Routines and rituals: a grounded theory of the pain management of drug users in acute care settings. J Clin Nurs. 2010;19(19–20):2730–2740.
34.
BergKM, ArnstenJH, SacajiuG, KaraszA.Providers’ experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med. 2009;24(4):482–488.
35.
LebovitsAH, FlorenceI, BathinaR, HunkoV, FoxMT, BrambleCY.Pain knowledge and attitudes of healthcare providers: practice characteristic differences. Clin J Pain. 1997;13(3):237–243.
36.
BaldacchinoA, GilchristG, FlemingR, BannisterJ.Guilty until proven innocent: a qualitative study of the management of chronic non-cancer pain among patients with a history of substance abuse. Addict Behav. 2010;35(3):270–272.
37.
VoonP, CallonC, NguyenP, . Denial of prescription analgesia among people who inject drugs in a Canadian setting. Drug Alcohol Rev. 2015;34(2):221–228.
38.
FibbiM, SilvaK, JohnsonK, LangerD, LankenauSE.Denial of prescription opioids among young adults with histories of opioid misuse. Pain Med. 2012;13(8):1040–1048.
39.
BrenerL, von HippelW, von HippelC, ResnickI, TreloarC.Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach. Drug Alcohol Rev. 2010;29(5):491–497.
40.
ShekarchizadehH, KhamiMR, MohebbiSZ, EkhtiariH, VirtanenJI.Oral health of drug abusers: a review of health effects and care. Iran J Public Health. 2013;42(9):929–940. https://pubmed.ncbi.nlm.nih.gov/26060654.
41.
RadloffLS, TheCES.D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
42.
NapperLE, FisherDG, JohnsonME, WoodMM.The reliability and validity of drug users’ self reports of amphetamine use among primarily heroin and cocaine users. Addict Behav. 2010;35(4):350–354.
